期刊文献+

bcl 10 gene mutation in hepatocellular carcinoma 被引量:1

bcl 10基因在人肝细胞肝癌中的突变(英文)
原文传递
导出
摘要 Abstract:Objective To detect the mutation frequency of the bcl 10 gene in the early and advanced stages of hepatocellular carcinoma (HCC).Methods Genome DNA samples were extracted from 46 cases of fresh HCC tumor tissues and their non-tumor adjacent tissues. Polymerase chain reaction-single strand conformation polymorphism method was used to detect point mutations of the three exons of the bcl 10 gene. For each individual exon, six random samples from those showing abnormal DNA bands were sequenced to verify those mutations. The relationship between serum alpha-fetoprotein (AFP) level and bcl 10 mutation, between the tumor size and bcl 10 mutation was also analyzed.Results Among the 46 samples, 26 cases (56.5%) were found to have mutations in exon 1, 5 out of the 6 cases were shown to have 5744 C→G mutation by sequencing; 25 cases (54.3%) were found to have mutations in exon 2, 4 out of the 6 cases were shown to have 11?311 T deletion mutation by sequencing. Twenty-one cases (45.7%) were found to have mutations in exon 3, all of the 6 cases selected for sequencing were shown to have 14?116 C→T mutation. Statistical analysis showed that neither serum alpha-fetoprotein level nor the size of hepatocellular carcinoma has a significant relationship with bcl 10 mutation.Conclusion The bcl 10 gene has a high mutation frequency in liver cancer. 目的 本文研究了bcl 10基因在早期和进展期人肝细胞肝癌中的突变频率。方法 提取 4 6例新鲜肝癌及癌周组织的基因组DNA ,应用聚合酶链式反应 单链构象多态性分析的方法 ,研究bcl 10基因 3个外显子的突变情况 ,并对每个外显子随即抽取 6例突变样本进行测序分析。同时分析bcl 10基因突变与血清甲胎蛋白水平以及肝癌大小的关系。结果  4 6例肝细胞肝癌中共检测到外显子 1突变 2 6例 ,占 5 6 5 % ,6例测序样本中有 5例表现为第 5 74 4位CG颠换突变 ;外显子 2突变 2 5例 ,占 5 4 3% ,6例测序样本中有 4例表现为第 11311位T碱基缺失突变 ;外显子 3突变 2 1例 ,占 4 5 7% ,6例测序样本皆表现为系第 14116位CT转换突变。统计分析表明bcl 10突变和血清甲胎蛋白水平以及肝癌大小没有相关关系。结论 bcl 10基因在肝癌中突变频率较高。
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2001年第7期75-79,109,共6页 中华医学杂志(英文版)
关键词 bcl 10 gene · liver cancer · mutation Bcl 10基因 肝癌 突变
  • 相关文献

参考文献11

  • 1Shiokawa S,Nishimura J,Ohshima K,et al.Establishment of a novel B cell clonality analysis using single-strand conformation polymorphism of immunoglobin light chain messenger signals. American Journal of Pathology . 1998
  • 2Koseki T,Inohara N,Chen S,et al.ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proceedings of the National Academy of Sciences of the United States of America . 1998
  • 3Willis TG,Dalal MJ,Du MQ,et al.bcl 10 is involved in t(1;14)(p22; q32) of MALT B-cell lymphoma and mutated in multiple tumor types. Cell . 1999
  • 4Zhang Q,Siebert R,Yan M,et al.bcl 10, Inactivating mutations and overexpression of bcl 10, a caspase recruitment domain-containing gene, in MALT lymphoma with t ( 1; 14 )q(p22;q32). Nature Genetics . 1999
  • 5Gualberto A,Aldape K,Kozakiewicz K,et al.An oncogenic form of p53 confers a dominant, gain-of-function phenotype that disrupts spindle checkpoint control. Proceedings of the National Academy of Sciences of the United States of America . 1998
  • 6Chou JJ,Matsuo H,Duan H,et al.Solution structures of the RAIDD CARD and model for CARD/CARD interaction in caspase-2 and caspase-9 recruitment. Cell . 1998
  • 7Cattoretti G,Chang CC,Cechova K,et al.Bcl-6 protein is expressed in germinal-center B cells. Blood . 1995
  • 8Chrambach A,Rodbard D.Polyacrylamide gel electrophoresis. Science . 1971
  • 9Kaczynski J,Hansson G,Wallerstedt S.Incidence of primary liver cancer and etiological aspects: a study of a defined population from a low-endemity area. British Journal of Cancer . 1996
  • 10Chen WJ,Chung YC.Energy expenditure in patients with hepatocellular carcinoma. Cancer . 1994

同被引文献11

  • 1OKUDA K, PETERS PL, SIMSON 1W. Gross anatomic features of hepatoceUular carcinoma from three disparate geographic areas: Proposal of new classification[J]. Cancer, 1984, 54: 2165-2173.
  • 2YAMAMOTO T, KAJINO K, KUDO M, et al. Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated of hepatitis B virus DNA[J]. Hepatology, 1999, 29(5): 1446-1452.
  • 3YASUI M, HARADA A, NONAMI T, et al. Potentially multicentric hepatocellular carcinoma: clinicopathologic characteristics and postoperative prognosis[J]. World J Surg, 1997, 21(8): 860-865.
  • 4NOMOTO S, YAMASHITA K, KOSHIKAWA K, et al. Mitochondrial D-Loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma [J]. Clin Cancer Res, 2002, 8(2): 481-487.
  • 5NOWELL PC. The clonal evolution of tumor cell populations[J]. Science, 1976, 194(4260): 23-28.
  • 6CALABRESE P, TAVAR 6 S, SHIBATA D. Pretumor progression: elonal evolution of human stem cell populations [J]. Am J Pathol, 2004, 164(4): 1337-1346.
  • 7HSU IC, METCAF RA, SUN T, et al. Mutational hot .spot in the P53 gene in human hepatocellular carcinoma [J]. Nature, 1991, 350: 427.
  • 8ZHANG Q, SIEBERT R, YAN M, et al. Inactivating mutations and overexpression of bcl-10, a caspase recruitment domain-containing gene, in MAL T lymphoma with t (1;14)(1322; q32)[J]. Nat Genet, 1999, 22: 63-68.
  • 9UTSUNOMIYA I. Pathological study on muhicentric occurrence of hepatocellular carcinoma [J]. KummeMed J, 2005, 52 (4): 133-138.
  • 10彭涛,黎乐群,林进令,巫山,陆云飞,肖强,曾健,廖清华,梁水庭.对非同位素PCR-SSCP检测基因突变方法的探讨[J].广西医科大学学报,1998,15(1):33-36. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部